• #47 - Bill Peters, CEO at On Target Laboratories

  • Feb 25 2025
  • Duración: 15 m
  • Podcast

#47 - Bill Peters, CEO at On Target Laboratories

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Join us on the latest episode! Our Guest: Bill Peters, CEO at On Target Laboratories.

    What you'll get out of this episode:

    • Innovative Imaging for Surgery – On Target Laboratories enables surgeons to see cancer at the cellular level using near-infrared imaging.
    • Cytalux for Lung & Ovarian Cancer – Their FDA-approved drug, Cytalux, helps identify tumors in real-time, improving surgical outcomes.
    • Surgeon-Driven Development – Continuous feedback from surgeons drives research, refining the technology for broader applications.
    • Future of Cancer Surgery – With ongoing clinical trials, On Target Laboratories aims to expand its imaging technology to new indications.
    • Industry Engagement – The company actively participates in key medical conferences, connecting with experts to advance cancer care.

    To Learn More About Our Guest And Their Company:
    Guest LinkedIn https://www.linkedin.com/in/bill-peters-749a332a/
    Company LinkedIn https://www.linkedin.com/company/on-target-laboratories-inc/
    Website http://www.ontargetlabs.com

    Our sponsor for this episode are:
    Sage Growth Partners https://sage-growth.com/

    BioBreakthroughs is part of the Slice of Healthcare podcast network:
    LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre #47 - Bill Peters, CEO at On Target Laboratories

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles